Edition:
United States

People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

37.67USD
21 Sep 2017
Change (% chg)

$0.05 (+0.13%)
Prev Close
$37.62
Open
$37.70
Day's High
$37.71
Day's Low
$37.00
Volume
179,029
Avg. Vol
299,041
52-wk High
$38.74
52-wk Low
$24.47

Kramer, Robert 

Mr. Robert G. Kramer Sr., is Chief Financial Officer, Executive Vice President, Administration, Treasurer of the Company. He is responsible for finance and administration, compliance, IT, investor relations, public affairs and external development and government contracts. Mr. Kramer first joined Emergent in 1999 as its chief financial officer. From 1999 until his retirement in 2010, he held various executive positions with the last being president of Emergent Biodefense Operations Lansing. Mr. Kramer returned to the company in 2011 as the interim head of the biosciences division, and then as interim executive vice president, corporate services division before taking his current position. Prior to joining Emergent in 1999, Mr. Kramer held various financial management positions at Pharmacia Corporation, which subsequently merged with the Upjohn Company in 1995 and eventually became part of Pfizer Inc. Mr. Kramer received an M.B.A. from Western Kentucky University and a B.S. in industrial management from Clemson University.

Basic Compensation

Total Annual Compensation, USD 501,655
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 973,401
Fiscal Year Total, USD 1,475,060

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 76,655 1,129,660.00
Name Fiscal Year Total

Fuad El-Hibri

2,428,930

Daniel Abdun-Nabi

3,185,070

Robert Kramer

1,475,060

Adam Havey

988,069

Ronald Richard

382,493

Sue Bailey

331,993
As Of  30 Dec 2016